NasdaqGS - Nasdaq Real Time Price USD

Bio-Techne Corporation (TECH)

50.89

+0.73

+(1.46%)

As of 3:54:17 PM EDT. Market Open.

Bio-Techne Corporation (TECH) Slid Due to NIH’s Funding Concerns

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market experienced a modest decline in Q1 2025, with the S&P 500 Index falling 4.27%, while bonds showed stability with the Bloomberg U.S. Aggregate Bond Index […]

Insider Monkey 6 hours ago

TECH
+1.46%
3 Healthcare Stocks Facing Headwinds

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 12.7%. This drop was worse than the S&P 500’s 7.5% loss.

StockStory 6 hours ago

MRNA

ZBH

TECH
+1.46%
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial biology: a powerful new assay for in situ detection of protein proximity. Built upon Advanced Cell Diagnostics RNAscope™ technology, this next-generation assay is designed to reveal functional interactions between proteins within intact tissues, delivering a spatial solution to explore how molecular signaling shapes disease pro

PR Newswire 8 hours ago

TECH
+1.46%
Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest advancements in cancer research tools at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30 at McCormick Place Convention Center in Chicago, IL. Bio-Techne's booths will feature its oncology research portfolio spanning early discovery, translational research, and cell and gene therapy development.

PR Newswire yesterday

TECH
+1.46%
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Illumina (NASDAQ:ILMN) and the rest of the life sciences tools & services stocks fared in Q4.

StockStory 6 days ago

ILMN

TECH
+1.46%
Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Agilent (NYSE:A) and its peers.

StockStory 6 days ago

A

TECH
+1.46%
AVTR
Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 7, 2025, at 8:00 a.m. CDT to review its third quarter fiscal 2025 financial results.

PR Newswire 9 days ago

TECH
+1.46%
Novavax slides after RFK Jr. casts doubts about COVID vaccine

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay. The Secretary of Health and Human Services pointed to the vaccine’s single-antigen composition as the reason for the push back, adding that the FDA is “shifting our priorities to multiple-antigen vaccines.” SHIFTING PRIORITIES: The Food and Drug Administration is sitting on the decision to grant full approval for Novavax COVID-19 shot. In an interview wit

TipRanks 13 days ago

PFE

NVAX

MRNA
Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength?

Bio-Techne (TECH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 14 days ago

TECH
+1.46%
NVCR
Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks

Let’s dig into the relative performance of Avantor (NYSE:AVTR) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.

StockStory 14 days ago

AVTR

TECH
+1.46%
SHC
Apple, Starbucks upgraded: Wall Street's top analyst calls

Apple, Starbucks upgraded: Wall Street's top analyst calls

The Fly 15 days ago

AAPL

SBUX

BBWI
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.

StockStory 15 days ago

TXG

TECH
+1.46%
WAT
+1.89%
A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack

Let’s dig into the relative performance of Mettler-Toledo (NYSE:MTD) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.

StockStory 16 days ago

MTD
+2.37%
TECH
+1.46%
AVTR
3 Small-Cap Stocks with Mounting Challenges

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

StockStory 19 days ago

AEIS

TECH
+1.46%
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a global leader in anatomic pathology solutions. The expanded spatial multiomic collaboration now includes automation of ACD's new RNAscope™ Multiomic LS Assay and protease-free workflows on Leica's BOND RX research staining instrument, further advancing the capabilities of spatial biology research.

PR Newswire 22 days ago

TECH
+1.46%
Bio-Techne Opens New Customer Experience Centre in Germany

TECH announces the opening of a new Customer Experience Centre to support long-term growth in the EMEA region. The new facility is located in Dusseldorf, Germany.

Zacks 24 days ago

TECH
+1.46%
QGEN
+1.77%
BIO-B
3 Reasons to Avoid TECH and 1 Stock to Buy Instead

Shareholders of Bio-Techne would probably like to forget the past six months even happened. The stock has dropped 26.9% and now trades at a new 52-week low of $58.44. This may have investors wondering how to approach the situation.

StockStory 24 days ago

TECH
+1.46%
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch

Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.

StockStory 27 days ago

TECH
+1.46%
AVTR

MTD
+2.37%
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region and support the company's long-term regional growth strategy.

PR Newswire 29 days ago

TECH
+1.46%
2 High-Flying Stocks to Target This Week and 1 to Brush Off

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.

StockStory last month

TECH
+1.46%
VEEV

Performance Overview

Return	TECH	S&P 500 (^GSPC)
YTD	-29.26%	-6.67%
1-Year	-19.54%	+8.23%
3-Year	-48.84%	+28.50%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bio-Techne Corporation (TECH)

Bio-Techne Corporation (TECH) Slid Due to NIH’s Funding Concerns

3 Healthcare Stocks Facing Headwinds

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results

Novavax slides after RFK Jr. casts doubts about COVID vaccine

Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength?

Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks

Apple, Starbucks upgraded: Wall Street's top analyst calls

Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks

A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack

3 Small-Cap Stocks with Mounting Challenges

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

Bio-Techne Opens New Customer Experience Centre in Germany

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

2 High-Flying Stocks to Target This Week and 1 to Brush Off

Performance Overview